Before you take a new drug, ask your doctor or pharmacist questions like: Can I take this with my other meds? Should I avoid certain foods, drinks, or other products? Could this medication ...

Remember, you should not change your dosage of Vraylar without your doctor’s recommendation. Only take Vraylar exactly as prescribed. Talk with your doctor if you have questions or concerns ...

There isn’t an alternative dosing schedule recommended for the drug. Talk with your doctor if you have questions about Wegovy’s dose schedule. Why is there a starting dose for Wegovy?

Whether you are beginning your career, looking to change your career or desire an advanced degree, Passan School of Nursing is the place for you. Our school has a strong commitment to the professional ...

A practice–focused terminal degree, the Doctor of Nursing Practice (DNP) Program prepares graduates to lead the translation of scientific evidence into best practices for improving population health ...

But with too few staff and inadequate gear, they’re no match for the most dangerous threat now lurking in the national parks, violent drug cartels.

Questions remain over the efficacy-to-safety ratio of Novo Nordisk’s acquired weight loss drug monlunabant after a Phase IIa trial. The pharma giant announced results from the study (NCT05891834 ...

A study led by clinician-scientists and researchers from the National Cancer Centre Singapore (NCCS) and Singapore General ...

How has Alzheimer's affected your family? What are your questions about the disease and the breakthrough drug? You can get in touch by emailing [email protected]. Please include a contact ...

It was released in advance of a United Nations General Assembly meeting later this month on drug-resistant pathogens. “The numbers in the Lancet paper represent a staggering and unacceptable ...

Most Medicare Advantage plans include drug coverage. People with Original ... If you have additional questions about Medicare, visit Medicare.gov or call 800-MEDICARE (800-633-4227, TTY 877-486-2048).

The treatment combines a new drug, inavolisib, with two older breast cancer drugs, fulvestrant (Faslodex ®) and palbociclib (Ibrance ®) . Inavolisib, which targets PIK3CA mutations, appears to be a ...